Determination of total homocysteine, methylmalonic acid, and 2-methylcitric acid in dried blood spots by tandem mass spectrometry

Clinical Chemistry

Volumn 56, Issue 11, 2010, Pages 1686-1695

  Turgeon, Coleman T ^a   Magera, Mark J ^a   Cuthbert, Carla D ^b   Loken, Perry R ^a   Gavrilov, Dimitar K ^a   Tortorelli, Silvia ^a   Raymond, Kimiyo M ^a   Oglesbee, Devin ^a   Rinaldo, Piero ^a   Matern, Dietrich ^a  

^a Mayo Clinic   (United States)

^b NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLCITRIC ACID; ACETONITRILE; BUTANOL; CITRIC ACID; DITHIOTHREITOL; FORMIC ACID; HOMOCYSTEINE; METHYLMALONIC ACID; UNCLASSIFIED DRUG; WATER; 2-METHYLCITRIC ACID;

ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); EVAPORATION; FALSE POSITIVE RESULT; HUMAN; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; NEWBORN; NEWBORN SCREENING; TANDEM MASS SPECTROMETRY; BLOOD; LABORATORY DIAGNOSIS; PREDICTION AND FORECASTING; REFERENCE VALUE; STATISTICAL PARAMETERS;

BLOOD SPECIMEN COLLECTION; CHROMATOGRAPHY, LIQUID; CITRATES; FALSE POSITIVE REACTIONS; HOMOCYSTEINE; HUMANS; INFANT, NEWBORN; LIMIT OF DETECTION; METHYLMALONIC ACID; NEONATAL SCREENING; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; TANDEM MASS SPECTROMETRY;

EID: 78149490509     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2010.148957     Document Type: Article

References (30)

1. Watson MS, Lloyd-Puryear MA, Mann MY, Rinaldo P, Howell RR. Newborn screening: toward a uniform screening panel and system [Executive Summary]. Genet Med 2006;8:1S-12S.
2. Peterschmitt MJ, Simmons JR, Levy HL. Reduction of false negative results in screening of newborns for homocystinuria. N Engl J Med 1999;341:1572-6.
3. ten Hoedt AE, van Kempen AA, Boelen A, Duran M, Kemper-Proper EA, Oey-Spauwen MJ, et al. High incidence of hypermethioninaemia in a single neonatal intensive care unit detected by a newly introduced neonatal screening programme. J Inherit Metab Dis 2007;30:978.
4. Chace DH, Hillman SL, Millington DS, Kahler SG, Adam BW, Levy HL. Rapid diagnosis of homocystinuria and other hypermethioninemias from newborns' blood spots by tandem mass spectrometry. Clin Chem 1996;42:349-55.
5. Chace DH, DiPerna JC, Kalas TA, Johnson RW, Naylor EW. Rapid diagnosis of methylmalonic and propionic acidemias: quantitative tandem mass spectrometric analysis of propionylcarnitine in filter-paper blood specimens obtained from newborns. Clin Chem 2001;47:2040-4.
6. Weisfeld-Adams JD, Morrissey MA, Kirmse BM, Salveson BR, Wasserstein MP, McGuire PJ, et al. Newborn screening and early biochemical follow-up in combined methylmalonic aciduria and homocystinuria, cblC type, and utility of methionine as a secondary screening analyte. Mol Genet Metab 2010;99:116-23.
7. Zschocke J, Kebbewar M, Gan-Schreier H, Fischer C, Fang-Hoffmann J, Wilrich J, et al. Molecular neonatal screening for homocystinuria in the Qatari population. Hum Mutat 2009;30:1021-2.
8. Gan-Schreier H, Kebbewar M, Fang-Hoffmann J, Wilrich J, Abdoh G, Ben-Omran T, et al. Newborn population screening for classic homocystinuria by determination of total homocysteine from Guthrie cards. J Pediatr 2010;156:427-32.
9. la Marca G, Malvagia S, Pasquini E, Innocenti M, Donati MA, Zammarchi E. Rapid 2nd-tier test for measurement of 3-OH-propionic and methylmalonic acids on dried blood spots: reducing the false-positive rate for propionylcarnitine during expanded newborn screening by liquid chromatography-tandem mass spectrometry. Clin Chem 2007;53:1364-9. (Pubitemid 47020995)
10. Matern D, Tortorelli S, Oglesbee D, Gavrilov D, Rinaldo P. Reduction of the false-positive rate in newborn screening by implementation of MS/MS-based second-tier tests: the Mayo Clinic experience (2004-2007). J Inherit Metab Dis 2007;30:585-92. (Pubitemid 47377054)
11. Magera MJ, Helgeson JK, Matern D, Rinaldo P. Methylmalonic acid measured in plasma and urine by stable-isotope dilution and electrospray tandem mass spectrometry. Clin Chem 2000;46:1804-10.
12. Magera MJ, Lacey JM, Casetta B, Rinaldo P. Method for the determination of total homocysteine in plasma and urine by stable isotope dilution and electrospray tandem mass spectrometry. Clin Chem 1999;45:1517-22. (Pubitemid 29419005)
13. Annesley TM. Ion suppression in mass spectrometry. Clin Chem 2003;49:1041-4.
14. Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 1963;32:338-43.
15. Kaufman S, Holtzman NA, Milstien S, Butler LJ, Krumholz A. Phenylketonuria due to a deficiency of dihydropteridine reductase. N Engl J Med 1975;293:785-90.
16. Danks DM, Cotton RG, Schlesinger P. Variant forms of phenylketonuria [Letter]. Lancet 1976;1:1236-7.
17. Tarini BA, Christakis DA, Welch HG. State newborn screening in the tandem mass spectrometry era: more tests, more false-positive results. Pediatrics 2006;118:448-56.
18. Rinaldo P, Zafari S, Tortorelli S, Matern D. Making the case for objective performance metrics in newborn screening by tandem mass spectrometry. Ment Retard Dev Disabil Res Rev 2006;12:255-61. (Pubitemid 46053451)
19. Campbell CD, Ganesh J, Ficicioglu C. Two newborns with nutritional vitamin B12 deficiency: challenges in newborn screening for vitamin B12 deficiency. Haematologica 2005;90:ECR45.
20. Marble M, Copeland S, Khanfar N, Rosenblatt DS. Neonatal vitamin B12 deficiency secondary to maternal subclinical pernicious anemia: identification by expanded newborn screening. J Pediatr 2008;152:731-3. (Pubitemid 351503542)
21. Chapman KA, Bennett MJ, Sondheimer N. Increased C3-Carnitine in a Healthy Premature Infant. Clin Chem 2008;54:1914-7.
22. Magera MJ, Gunawardena ND, Hahn SH, Tortorelli S, Mitchell GA, Goodman SI, et al. Quantitative determination of succinylacetone in dried blood spots for newborn screening of tyrosinemia type I. Mol Genet Metab 2006;88:16-21.
23. la Marca G, Malvagia S, Casetta B, Pasquini E, Donati MA, Zammarchi E. Progress in expanded newborn screening for metabolic conditions by LC-MS/MS in Tuscany: update on methods to reduce false tests. J Inherit Metab Dis 2008 Oct 27. DOI: 10.1007/s10545-008-0965-z. JIMD short report #127 (2008) online.
24. Oglesbee D, Sanders KA, Lacey JM, Magera MJ, Casetta B, Strauss KA, et al. Second-tier test for quantification of alloisoleucine and branched-chain amino acids in dried blood spots to improve newborn screening for maple syrup urine disease (MSUD). Clin Chem 2008;54:542-9. (Pubitemid 351348164)
25. Turgeon C, Magera MJ, Allard P, Tortorelli S, Gavrilov D, Oglesbee D, et al. Combined newborn screening for succinylacetone, amino acids, and acylcarnitines in dried blood spots. Clin Chem 2008;54:657-64. (Pubitemid 351573716)
26. la Marca G, Malvagia S, Pasquini E, Innocenti M, Fernandez MR, Donati MA, Zammarchi E. The inclusion of succinylacetone as marker for tyrosinemia type I in expanded newborn screening programs. Rapid Commun Mass Spectrom 2008;22:812-8. (Pubitemid 351442555)
27. Tortorelli S, Turgeon CT, Lim JS, Baumgart S, Day-Salvatore DL, Abdenur J, et al. A two-tier approach to the newborn screening of methylenetetrahydrofolate reductase deficiency and other remethylation disorders by tandem mass spectrometry. J Pediatr 2010:157;271-5.
28. Shinawi M. Hyperhomocysteinemia and cobalamin disorders. Mol Genet Metab 2007;90:113-21.
29. Kirk K, Steckel T, King P, Kline D, Rhoades E, Copeland K. A second-tier screening approach for CAH: Oklahoma's experience. 2007 Newborn Screening and Genetic Testing Symposium; 2007 May 7-10; Minneapolis, Minn. http://www.aphl.org/profdev/conferences/proceedings/Pages/ 2007APHLNBSandGeneticsTestingSymposium.aspx (Accessed September 2010).
30. De Jesús VR, Mei JV, Bell CJ, Hannon WH. Improving and assuring newborn screening laboratory quality worldwide: 30-year experience at the centers for disease control and prevention. Semin Perinatol 2010;34:125-33.